Global Leader, McKinsey Digital
McKinsey & Company
Rodney W. Zemmel is a Senior Partner at McKinsey & Company, where he serves as the Managing Partner of McKinsey’s Northeast Office, which includes McKinsey’s New York, Boston, and Stamford locations. He is one of the leaders of the Firm’s Healthcare practice.
Since joining McKinsey in 1995, Mr. Zimmel has advised clients across the healthcare spectrum, working with leading companies in pharmaceuticals, health insurance, and healthcare benefit management, and with hospital systems, academic medical centers. He has helped clients on long term strategy and near term performance, both in their core businesses, and in new growth areas. He has helped develop strategies for clients responding to major market developments, such as US healthcare reform, and R&D productivity challenges. He has worked extensively on mergers & acquisitions, partnerships, reorganizations, and has supported the launch and growth strategies of leading products in the US, Europe, and Asia, helping to deliver important benefits to patients, and improved business results for clients. Mr. Zemmel has also led McKinsey’s support for a number of private equity clients, and on growth strategy across industries.
A recognized thought leader in the healthcare and general business community, he has authored articles in leading business publications from The Harvard Business Review to Nature Reviews Drug Discovery, and is an author of McKinsey’s latest “Accounting for the Cost of U.S. Health Care” report. He is a frequent speaker at industry conferences and represents McKinsey at forums such as the National Association of Corporate Directors and CEO round tables.
He received a Ph.D. in molecular biology, along with a first class BA/MA degree in natural sciences, all from Trinity College, Cambridge, UK. He serves as a board member of BritishAmerican Business.